LXEO

LXEO Operating Cash Flow (Statement)

-$88.37MTTM · USD

Period ending:

LXEO FY Cash from OperationsUSD
LXEO FY Cash from Operations2020-12-31: -$3.13M2021-12-31: -$44.18M2022-12-31: -$54.56M2023-12-31: -$59.50M2024-12-31: -$81.15M2025-12-31: -$98.56M$0.00-$98.56M
2020-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

LXEO operating cash flow (statement) history

Net cash provided by operating activities. The available annual fiscal periods series contains 6 observations from Dec 31, 2020 to Dec 31, 2025.

Lexeo Therapeutics Inc Operating Cash Flow (Statement) — Annual fiscal periods (USD)
Period endingOperating Cash Flow (Statement) (USD)
-98,561,000
-81,151,000
-59,496,000
-54,560,000
-44,182,000
-3,133,396

Compare operating cash flow (statement)

All LXEO financial metrics · LXEO stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.